| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLYCOPYRROLATE | 212467 | 001 | ANDA | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No | 2022/07/05 | 2022/07/05 | SUVEN PHARMS | Prescription |
| GLYCOPYRROLATE | 213698 | 001 | ANDA | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No | 2022/07/05 | 2022/07/05 | ANNORA PHARMA | Prescription |
| GLYCOPYRROLATE | 215333 | 001 | ANDA | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No | 2022/10/21 | 2022/10/21 | AMNEAL | Prescription |
| GLYCOPYRROLATE | 214635 | 001 | ANDA | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No | 2022/10/26 | 2022/10/26 | ALEMBIC | Prescription |
| GLYCOPYRROLATE | 212871 | 001 | ANDA | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No | 2022/11/28 | 2022/11/29 | OMNIVIUM PHARMS | Prescription |
| GLYCOPYRROLATE | 213655 | 001 | ANDA | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No | 2023/02/07 | 2023/02/07 | LUPIN LTD | Discontinued |
| GLYCOPYRROLATE | 217354 | 001 | ANDA | GLYCOPYRROLATE | INJECTABLE;INJECTION | 0.2MG/ML | No | No | 2023/02/27 | 2023/02/27 | MANKIND PHARMA | Discontinued |
| GLYCOPYRROLATE | 212696 | 001 | ANDA | GLYCOPYRROLATE | TABLET;ORAL | 1MG | No | No | 2024/07/10 | 2024/07/10 | QUAGEN | Prescription |
| GLYCOPYRROLATE | 212696 | 002 | ANDA | GLYCOPYRROLATE | TABLET;ORAL | 2MG | No | No | 2024/07/10 | 2024/07/10 | QUAGEN | Prescription |
| GLYCOPYRROLATE | 214735 | 001 | ANDA | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No | 2024/08/19 | 2024/08/19 | GRANULES | Prescription |
| GLYCOPYRROLATE | 216368 | 001 | ANDA | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No | 2024/08/28 | 2024/08/28 | CHARTWELL RX | Prescription |
| GLYCOPYRROLATE | 216297 | 001 | ANDA | GLYCOPYRROLATE | SOLUTION;ORAL | 1MG/5ML | No | No | 2024/10/07 | 2024/10/07 | SAPTALIS PHARMS | Prescription |